First National Bank Sioux Falls’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-200
Closed -$10K 233
2016
Q1
$10K Hold
200
0.03% 190
2015
Q4
$10K Hold
200
0.03% 192
2015
Q3
$10K Hold
200
0.03% 186
2015
Q2
$10K Sell
200
-480
-71% -$27K 0.03% 194
2015
Q1
$39K Hold
680
0.11% 123
2014
Q4
$36K Buy
680
+80
+13% +$4.48K 0.1% 123
2014
Q3
$34K Buy
600
+400
+200% +$24.5K 0.09% 124
2014
Q2
$13K Hold
200
0.03% 164
2014
Q1
$13K Hold
200
0.04% 160
2013
Q4
$13K Hold
200
0.03% 162
2013
Q3
$13K Hold
200
0.04% 156
2013
Q2
$12K Buy
+200
New +$12.7K 0.03% 158

Other funds holding GSK

First National Bank Sioux Falls's GSK Position: Q2 2016 in Review

First National Bank Sioux Falls sold out of GSK (GSK) in Q2 2016, closing a stake of 200 shares — an estimated $10K sold.

First National Bank Sioux Falls first reported a position in GSK in Q2 2013 and held it in 12 quarters. The position peaked at $39K in Q1 2015. 741 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

  • First National Bank Sioux Falls reported no remaining GSK position as of Q2 2016 after selling out during the quarter.
  • First National Bank Sioux Falls sold 200 GSK shares in Q2 2016, an estimated $10K.
  • First National Bank Sioux Falls first reported a position in GSK in Q2 2013 and held it in 12 quarters.
  • First National Bank Sioux Falls's GSK position peaked at $39K in Q1 2015.
  • 741 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on First National Bank Sioux Falls's 13F filing for Q2 2016, filed 25 Jul 2016.